NasdaqGS - Delayed Quote USD

Sanofi (SNY)

46.30 +0.91 (+2.00%)
At close: April 19 at 4:00 PM EDT
46.63 +0.33 (+0.71%)
After hours: April 19 at 4:51 PM EDT

Valuation Measures

Currency in USD Download
Current12/31/20239/30/20236/30/20233/31/2023
Market Cap 115.44B 124.55B 134.37B 133.56B 136.50B
Enterprise Value 125.49B 138.97B 148.14B 142.05B 145.02B
Trailing P/E 20.18 12.45 14.83 14.92 14.99
Forward P/E 11.29 11.17 11.79 12.02 11.99
PEG Ratio (5yr expected) 0.85 2.48 2.46 4.42 3.31
Price/Sales 2.35 2.47 2.76 2.69 2.76
Price/Book 1.46 1.55 1.75 1.66 1.67
Enterprise Value/Revenue 2.70 11.39 11.67 13.30 13.35
Enterprise Value/EBITDA 9.96 327.00 37.83 56.14 46.58
3/31/2023 - 7/1/2002
All Historical Valuation Measures Unlock Access

Financial Highlights

Fiscal Year

Fiscal Year Ends 12/31/2023
Most Recent Quarter (mrq) 12/31/2023

Profitability

Profit Margin 11.73%
Operating Margin (ttm) 6.91%

Management Effectiveness

Return on Assets (ttm) 4.54%
Return on Equity (ttm) 7.27%

Income Statement

Revenue (ttm) 46.03B
Revenue Per Share (ttm) 18.39
Quarterly Revenue Growth (yoy) 2.90%
Gross Profit (ttm) --
EBITDA 12.52B
Net Income Avi to Common (ttm) 5.4B
Diluted EPS (ttm) 2.30
Quarterly Earnings Growth (yoy) --

Balance Sheet

Total Cash (mrq) 8.71B
Total Cash Per Share (mrq) 6.98
Total Debt (mrq) 18.42B
Total Debt/Equity (mrq) 24.78%
Current Ratio (mrq) 1.27
Book Value Per Share (mrq) 59.17

Cash Flow Statement

Operating Cash Flow (ttm) 10.26B
Levered Free Cash Flow (ttm) 8.19B

Trading Information

Stock Price History

Beta (5Y Monthly) 0.45
52 Week Range 3 -18.21%
S&P 500 52-Week Change 3 20.07%
52 Week High 3 57.82
52 Week Low 3 42.63
50-Day Moving Average 3 47.49
200-Day Moving Average 3 50.07

Share Statistics

Avg Vol (3 month) 3 1.98M
Avg Vol (10 day) 3 2.54M
Shares Outstanding 5 2.5B
Implied Shares Outstanding 6 2.52B
Float 8 1.1B
% Held by Insiders 1 0.00%
% Held by Institutions 1 9.94%
Shares Short (3/28/2024) 4 4.59M
Short Ratio (3/28/2024) 4 2.34
Short % of Float (3/28/2024) 4 --
Short % of Shares Outstanding (3/28/2024) 4 0.16%
Shares Short (prior month 2/29/2024) 4 4.31M

Dividends & Splits

Forward Annual Dividend Rate 4 2.04
Forward Annual Dividend Yield 4 4.40%
Trailing Annual Dividend Rate 3 3.76
Trailing Annual Dividend Yield 3 8.28%
5 Year Average Dividend Yield 4 3.72
Payout Ratio 4 82.36%
Dividend Date 3 6/23/2023
Ex-Dividend Date 4 5/9/2024
Last Split Factor 2 --
Last Split Date 3 --

Footnotes

  • 1 Data provided by Refinitiv.
  • 2 Data provided by EDGAR Online.
  • 3 Data derived from multiple sources or calculated by Yahoo Finance.
  • 4 Data provided by Morningstar, Inc.
  • 5 Shares outstanding is taken from the most recently filed quarterly or annual report and Market Cap is calculated using shares outstanding.
  • 6 Implied Shares Outstanding of common equity, assuming the conversion of all convertible subsidiary equity into common.
  • 7 EBITDA is calculated by S&P Global Market Intelligence using methodology that may differ from that used by a company in its reporting.
  • 8 A company's float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which may not be publicly traded.

Abbreviation Guide

  • mrq = Most Recent Quarter
  • ttm = Trailing Twelve Months
  • yoy = Year Over Year
  • lfy = Last Fiscal Year
  • fye = Fiscal Year Ending
See for definitions of terms used.

Related Tickers

NVS Novartis AG
94.36
+1.93%
 
GSK GSK plc
39.75
+1.22%
 
RHHBY Roche Holding AG
30.41
+1.20%
 
AZN AstraZeneca PLC
68.55
+0.28%
 
BMY Bristol-Myers Squibb Company
48.93
+1.30%
 
GILD Gilead Sciences, Inc.
66.76
+0.91%
 
AMGN Amgen Inc.
268.93
+2.35%
 
BIIB Biogen Inc.
194.38
+2.03%
 
MRK Merck & Co., Inc.
125.78
+0.44%
 
OGN Organon & Co.
17.82
-0.22%